SFP
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
End Stage Renal Disease
Conditions
End Stage Renal Disease, Chronic Kidney Disease
Trial Timeline
Nov 1, 2011 → Jan 1, 2014
NCT ID
NCT01503021About SFP
SFP is a phase 3 stage product being developed by Rockwell Medical for End Stage Renal Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT01503021. Target conditions include End Stage Renal Disease, Chronic Kidney Disease.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01503021 | Phase 3 | Completed |
Competing Products
20 competing products in End Stage Renal Disease